Susquehanna International Group, LLP Procept Bio Robotics Corp Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$56.31 - $84.99 $394,170 - $594,930	7,000 Added 10.23%	75,400 $6.04 Million
Q2 2024 Aug 15, 2024	SELL	$45.73 - $69.19 $3.82 Million - $5.78 Million	-83,600 Reduced 55.0%	68,400 $4.18 Million
Q1 2024 May 07, 2024	BUY	$40.38 - $50.75 $2.64 Million - $3.32 Million	65,500 Added 75.72%	152,000 $7.51 Million
Q4 2023 Feb 14, 2024	BUY	$24.89 - $43.41 $836,304 - $1.46 Million	33,600 Added 63.52%	86,500 $3.63 Million
Q3 2023 Nov 14, 2023	BUY	$30.02 - $38.81 $1.3 Million - $1.68 Million	43,200 Added 445.36%	52,900 $1.74 Million
Q2 2023 Aug 11, 2023	SELL	$26.7 - $37.02 $5.01 Million - $6.95 Million	-187,800 Reduced 95.09%	9,700 $342,000
Q1 2023 May 16, 2023	BUY	$26.64 - $39.74 $2.38 Million - $3.54 Million	89,200 Added 82.36%	197,500 $5.61 Million
Q4 2022 Feb 14, 2023	BUY	$38.78 - $46.78 $100,828 - $121,628	2,600 Added 2.46%	108,300 $4.5 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $50.65 $231,750 - $379,875	7,500 Added 7.64%	105,700 $4.38 Million

266

38M

262K

257K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $3.62B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.